drugset / Trial / NCT06744439

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

NCT06744439 ↗

Phase 1 Completed 49 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015 and co-administration of BR1015-3 and BR1015-2 in healthy volunteers under fed conditions

Timeline

Start
2025-01-09
Primary completion
2025-03-16
Completion
2025-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1015 Unknown — —
Comparator BR1015-2 Unknown — —
Comparator BR1015-3 Unknown — —